Total Payments
$113,102
2024 Payments
$355.80
Companies
23
Transactions
172
Medicare Patients
13,546
Medicare Billing
$11.9M
Payment Breakdown by Category
Other$84,594 (74.8%)
Consulting$14,081 (12.5%)
Travel$8,175 (7.2%)
Food & Beverage$6,154 (5.4%)
Education$99.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $75,662 | 23 | 66.9% |
| Consulting Fee | $14,081 | 8 | 12.5% |
| Travel and Lodging | $8,175 | 13 | 7.2% |
| Food and Beverage | $6,154 | 116 | 5.4% |
| Acquisitions | $5,543 | 1 | 4.9% |
| Current or prospective ownership or investment interest | $3,388 | 5 | 3.0% |
| Education | $99.00 | 1 | 0.1% |
| Unspecified | $0 | 5 | 0.0% |
Payments by Type
General
$113,102
167 transactions
Ownership
$0
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $84,992 | 73 | $0 (2024) |
| US Retina LLC | $8,931 | 11 | $0 (2023) |
| TissueTech, Inc. | $6,891 | 5 | $0 (2020) |
| Allergan, Inc. | $6,173 | 13 | $0 (2020) |
| Alimera Sciences, Inc. | $2,144 | 3 | $0 (2019) |
| OnMark, Inc. | $831.26 | 3 | $0 (2022) |
| Genentech USA, Inc. | $551.99 | 20 | $0 (2024) |
| Alcon Laboratories Inc | $460.26 | 4 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $364.28 | 10 | $0 (2020) |
| NotalVision | $292.54 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $355.80 | 9 | Alcon Vision LLC ($135.42) |
| 2023 | $6,114 | 18 | US Retina LLC ($5,543) |
| 2022 | $2,758 | 16 | US Retina LLC ($1,552) |
| 2021 | $18,198 | 26 | Regeneron Healthcare Solutions, Inc. ($16,979) |
| 2020 | $17,018 | 22 | Regeneron Healthcare Solutions, Inc. ($9,365) |
| 2019 | $24,871 | 30 | Regeneron Healthcare Solutions, Inc. ($23,886) |
| 2018 | $28,294 | 28 | Regeneron Healthcare Solutions, Inc. ($21,703) |
| 2017 | $15,494 | 23 | Regeneron Healthcare Solutions, Inc. ($12,782) |
All Payment Transactions
172 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/30/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: Ophthalmology | ||||||
| 07/23/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/09/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $30.67 | General |
| Category: Ophthalmology | ||||||
| 05/12/2024 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $135.42 | General |
| Category: Ophthalmology | ||||||
| 05/10/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $30.25 | General |
| Category: Ophthalmology | ||||||
| 03/22/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/07/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $29.14 | General |
| Category: Immunology and Ophthalmology | ||||||
| 01/26/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Immunology and Ophthalmology | ||||||
| 01/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/10/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/22/2023 | US Retina LLC | — | Acquisitions | Cash or cash equivalent | $5,543.00 | General |
| 10/19/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $78.37 | General |
| 10/06/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/06/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $24.83 | General |
| 09/09/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/25/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/16/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/01/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $18.18 | General |
| Category: Ophthalmology | ||||||
| 07/07/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $30.71 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/02/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/17/2023 | US Oncology Corporate, Inc. | — | Food and Beverage | Cash or cash equivalent | $43.73 | General |
| 05/10/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/31/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/24/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/24/2023 | Regeneron Pharmaceuticals, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $143.22 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 3,784 | 88,477 | $6.6M | $3.5M |
| 2022 | 17 | 3,360 | 17,044 | $6.0M | $3.0M |
| 2021 | 18 | 3,559 | 13,741 | $6.2M | $3.1M |
| 2020 | 16 | 2,843 | 10,353 | $4.7M | $2.3M |
Total Patients
13,546
Total Services
129,615
Medicare Billing
$11.9M
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 208 | 78,180 | $3.5M | $2.3M | 65.1% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 161 | 868 | $1.1M | $606,691 | 56.4% |
| 67028 | Injection of drug into eye | Office | 2023 | 277 | 1,792 | $1.0M | $174,140 | 16.9% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 622 | 1,161 | $197,370 | $112,132 | 56.8% |
| 92134 | Imaging of retina | Office | 2023 | 786 | 3,096 | $297,216 | $101,922 | 34.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 426 | 1,130 | $135,600 | $79,586 | 58.7% |
| J3490 | Unclassified drugs | Office | 2023 | 16 | 32 | $81,920 | $56,540 | 69.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 261 | 501 | $51,102 | $38,543 | 75.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 101 | 101 | $21,715 | $11,986 | 55.2% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 485 | 963 | $92,448 | $11,798 | 12.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 136 | 223 | $21,185 | $10,858 | 51.3% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 162 | 224 | $21,504 | $4,214 | 19.6% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 19 | 64 | $6,400 | $3,629 | 56.7% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 11 | 14 | $14,392 | $2,722 | 18.9% |
| 92250 | Photography of the retina | Office | 2023 | 60 | 69 | $6,693 | $1,644 | 24.6% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 13 | 13 | $2,925 | $1,584 | 54.2% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 28 | 28 | $1,400 | $529.32 | 37.8% |
| 67820 | Removal of eyelashes using forceps | Office | 2023 | 12 | 18 | $2,880 | $293.19 | 10.2% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 219 | 2,797 | $3.5M | $2.0M | 58.1% |
| 67028 | Injection of drug into eye | Office | 2022 | 251 | 1,727 | $966,900 | $167,225 | 17.3% |
| J3490 | Unclassified drugs | Office | 2022 | 26 | 84 | $225,120 | $153,114 | 68.0% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 38 | 4,560 | $203,695 | $136,076 | 66.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 463 | 1,767 | $212,040 | $133,086 | 62.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 664 | 1,247 | $211,990 | $124,179 | 58.6% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 18 | 470 | $242,520 | $105,935 | 43.7% |
About Dr. Atul Jain, M.D
Dr. Atul Jain, M.D is a Ophthalmology healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1194905711.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Atul Jain, M.D has received a total of $113,102 in payments from pharmaceutical and medical device companies, with $355.80 received in 2024. These payments were reported across 172 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($75,662).
As a Medicare-enrolled provider, Jain has provided services to 13,546 Medicare beneficiaries, totaling 129,615 services with total Medicare billing of $11.9M. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location San Diego, CA
- Active Since 11/12/2007
- Last Updated 08/26/2010
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1194905711
Products in Payments
- EYLEA (Biological) $50,666
- EYLEA AFLIBERCEPT INJECTION (Biological) $34,484
- Prokera (Device) $6,891
- OZURDEX (Drug) $6,154
- Iluvien (Biological) $2,125
- Constellation (Device) $707.66
- ForeseeHome (Device) $292.54
- Lucentis (Biological) $259.24
- Vabysmo (Drug) $257.24
- YUTIQ (Drug) $237.38
- Spectralis (Device) $137.21
- PROKERA (Device) $106.77
- BEOVU (Drug) $81.97
- ClosureFast (Device) $80.68
- VABYSMO (Drug) $77.57
- OMNI (Device) $77.22
- Cimerli (Biological) $60.92
- EYLEA HD (Biological) $55.54
- ILEVRO (Drug) $42.36
- Izervay (Drug) $25.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in San Diego
Nikolas London, M.d, M.D
Ophthalmology — Payments: $545,087
Ophthalmology $545,087
Dr. Robert Weinreb, Md, MD
Ophthalmology — Payments: $515,649
Ophthalmology $515,649
Dr. Eric Nudleman, M.d., Ph.d, M.D., PH.D
Ophthalmology — Payments: $335,929
Ophthalmology $335,929
Dr. Michael Gordon, M.d, M.D
Ophthalmology — Payments: $190,040
Ophthalmology $190,040
Dr. Kimberly Cockerham, Md, MD
Ophthalmology — Payments: $176,635
Ophthalmology $176,635
Dr. Manoj Motwani, M.d, M.D
Ophthalmology — Payments: $165,397
Ophthalmology $165,397